Overview
You are the Key to Expanding Access to Care
-
- The Comprehensive Addiction and Recovery Act (CARA) of 2016 granted nurse practitioners and physician assistants the authority to prescribe the lifesaving medication Buprenorphine to treat Opioid Use Disorder.
- 30 million people are without access to Medication Assisted Treatment such Buprenorphine.
- Rural parts of the country are disproportionately affected by the provider shortage, particularly across the Midwest.
- Reports show that physicians are shying away from Buprenorphine certification due to low reimbursement rates, strict DEA regulations, and stigma.
- A 2012 AHRQ report identified that APRNs are mostly likely to practice in large, small and remote rural communities most affected by the shortage of waivered physician.
- Every day patients are turned away from treatment and face long waits to see a provider risking overdose, exposure to hepatitis or even HIV.
Watch “Medication to Treat Opioid Use Disorder”
Running time 2:25 minutes
60]
Watch “I’m Ready to Prescribe” PowerPoint Presentation
Running time: 8:22 minutes
Notes Page-I’m Ready to Prescribe.pdf – Click to print presentation
Steps to Applying for a Waiver.pdf
Review the “Medication Assisted Treatment” Infographic
Medication Assisted Treatment for Opioid Use Disorder 2017 AACN-NIDA.pdf
Resources and Other Training
SAMSHA Medication Pocket Cards
SMA16-4892PG-Pocket Guide MAT.pdf
Additional Training & Resources
PCSSMAT
Waiver Training Link
Primary Care Example of Successful Implementation
Fiellin_et_al-2008-The_American_Journal_on_Addictions-Primary Care Example.pdf